ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Increase Cancer Center Grants More Than R01s, SPOREs, Report Tells NCI

February 28, 2003

Smoking & Health Contractors Meet

July 11, 1975

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

Autologous BMT Equivalent To Allogeneic For Myeloma

December 31, 2010

Post Reporter Responds To Criticism Of Cancer Series

January 1, 1982

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981